Drugs / Halobetasol
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00715975 | Jul 2008 → May 2010 | psoriasis | Azidus Brasil | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05872256 | Jun → Nov 2023 | psoriasis | Dermatology Consulting Services, PLLC | Completed | No outcome recorded |
| Phase 4 | NCT03212963 | Mar 2017 → Aug 2019 | psoriasis | Sun Pharmaceutical Industries, Inc. | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01404338 Comparator | Jun 2011 → ? | psoriasis | Patel, Rita Vikram, M.D. | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06042647 Comparator | Jul → Nov 2023 | psoriasis | Dermatology Consulting Services, PLLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Halobetasol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05872256 ↗ |
| Route | Topical | “Topical Halobetasol Propionate” NCT00715975 ↗ |